These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 10612447

  • 1. Characterization of [125I]AR-M100613, a high-affinity radioligand for delta opioid receptors.
    Fraser GL, Labarre M, Godbout C, Butterworth J, Clarke PB, Payza K, Schmidt R.
    Peptides; 1999 Nov; 20(11):1327-35. PubMed ID: 10612447
    [Abstract] [Full Text] [Related]

  • 2. Comparison between delta-opioid receptor functional response and autoradiographic labeling in rat brain and spinal cord.
    Pradhan AA, Clarke PB.
    J Comp Neurol; 2005 Jan 24; 481(4):416-26. PubMed ID: 15593339
    [Abstract] [Full Text] [Related]

  • 3. [D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.
    Knapp RJ, Sharma SD, Toth G, Duong MT, Fang L, Bogert CL, Weber SJ, Hunt M, Davis TP, Wamsley JK.
    J Pharmacol Exp Ther; 1991 Sep 24; 258(3):1077-83. PubMed ID: 1653834
    [Abstract] [Full Text] [Related]

  • 4. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 24; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of [D-Ala2,4'-125I-Phe3,Glu4]deltorphin and characterization of its delta opioid receptor binding properties.
    Fang L, Knapp RJ, Matsunaga T, Weber SJ, Davis T, Hruby VJ, Yamamura HI.
    Life Sci; 1992 Dec 24; 51(20):PL189-93. PubMed ID: 1331636
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI.
    J Pharmacol Exp Ther; 1994 Feb 24; 268(2):836-46. PubMed ID: 8113996
    [Abstract] [Full Text] [Related]

  • 7. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 8. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW, Berezowska I, Nguyen TM, Schmidt R, Lemieux C, Chung NN, Falcone-Hindley ML, Yao W, Liu J, Iwama S, Smith AB, Hirschmann R.
    J Med Chem; 2000 Feb 24; 43(4):551-9. PubMed ID: 10691681
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
    Contreras PC, Tam L, Drower E, Rafferty MF.
    Brain Res; 1993 Feb 26; 604(1-2):160-4. PubMed ID: 8384509
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [125I][D-Ala2]deltorphin-I: a high affinity, delta-selective opioid receptor ligand.
    Dupin S, Tafani JA, Mazarguil H, Zajac JM.
    Peptides; 1991 Feb 26; 12(4):825-30. PubMed ID: 1664947
    [Abstract] [Full Text] [Related]

  • 14. Quantitative autoradiographic mapping of delta-opioid receptors in the rat central nervous system using [125I][D.Ala2]deltorphin-I.
    Gouardères C, Tellez S, Tafani JA, Zajac JM.
    Synapse; 1993 Mar 26; 13(3):231-40. PubMed ID: 8388577
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 16. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC, Lee H, Harrison C, Clark MJ, Song HF, Naughton NN, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2003 Jul 16; 306(1):179-86. PubMed ID: 12676881
    [Abstract] [Full Text] [Related]

  • 17. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY, Yang HH, Li S, Adams JU.
    J Pharmacol Exp Ther; 1995 Jun 16; 273(3):1047-56. PubMed ID: 7791074
    [Abstract] [Full Text] [Related]

  • 18. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
    Schoffelmeer AN, Yao YH, Gioannini TL, Hiller JM, Ofri D, Roques BP, Simon EJ.
    J Pharmacol Exp Ther; 1990 Apr 16; 253(1):419-26. PubMed ID: 2158552
    [Abstract] [Full Text] [Related]

  • 19. Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain.
    Yamamura MS, Horvath R, Toth G, Otvos F, Malatynska E, Knapp RJ, Porreca F, Hruby VJ, Yamamura HI.
    Life Sci; 1992 Apr 16; 50(16):PL119-24. PubMed ID: 1313133
    [Abstract] [Full Text] [Related]

  • 20. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
    Szatmári I, Orosz G, Medzihradszky K, Borsodi A.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):513-9. PubMed ID: 10558900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.